Call for Applications for the Rare‑to‑Common Neurodegeneration Impact Prize

Deadline: 31 August 2026

Call for Applications for the Rare‑to‑Common Neurodegeneration Impact Prize

Website and registration
Programme

The Impact Prize is a new research award of the NCL Foundation with a total funding of 200,000 EUR.

The prize supports collaborative research projects that bring together expertise in CLN3 (Batten disease) and more common neurodegenerative or age‑related disorders.

NCL (neuronal ceroid lipofuscinosis) is a rare, fatal neurodegenerative disease of childhood characterized by progressive loss of vision, cognitive and motor functions. The NCL Foundation is dedicated to advancing research on NCL and fostering international collaboration to accelerate therapeutic development. By connecting rare disease research with more common conditions such as Alzheimer’s disease or AMD, the prize aims to enable new cross‑disciplinary insights and therapeutic approaches.

We would greatly appreciate your support in sharing this call within your networks. We kindly invite you to:
• circulate it to relevant researchers
• include it in newsletters or mailing lists
• share it via your website or communication channels

If researchers are interested but still looking for a suitable collaboration partner, we are happy to support matchmaking. We also recommend our booklet with NCL-Lab Profiles worldwide: https://www.ncl-stiftung.de/english/ncl-labs/

You can find the full call attached and here: https://www.ncl-stiftung.de/english/what-we-do/

The deadline for the project outline is August 31, 2026.